44 related articles for article (PubMed ID: 8444841)
1. Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor.
Ishihara M; Tyrrell DJ; Stauber GB; Brown S; Cousens LS; Stack RJ
J Biol Chem; 1993 Mar; 268(7):4675-83. PubMed ID: 8444841
[TBL] [Abstract][Full Text] [Related]
2. A heparin-mimicking polymer conjugate stabilizes basic fibroblast growth factor.
Nguyen TH; Kim SH; Decker CG; Wong DY; Loo JA; Maynard HD
Nat Chem; 2013 Mar; 5(3):221-7. PubMed ID: 23422564
[TBL] [Abstract][Full Text] [Related]
3. Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography.
Platonova N; Miquel G; Chiu LY; Taouji S; Moroni E; Colombo G; Chevet E; Sue SC; Bikfalvi A
PLoS One; 2014; 9(10):e110055. PubMed ID: 25299071
[TBL] [Abstract][Full Text] [Related]
4. Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers.
Ishihara M; Nakamura S; Sato Y; Takayama T; Fukuda K; Fujita M; Murakami K; Yokoe H
Molecules; 2019 Dec; 24(24):. PubMed ID: 31861225
[TBL] [Abstract][Full Text] [Related]
5. Heparin-Mimicking Polymers: Synthesis and Biological Applications.
Paluck SJ; Nguyen TH; Maynard HD
Biomacromolecules; 2016 Nov; 17(11):3417-3440. PubMed ID: 27739666
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 2 dimer with superagonist in vitro activity improves granulation tissue formation during wound healing.
Decker CG; Wang Y; Paluck SJ; Shen L; Loo JA; Levine AJ; Miller LS; Maynard HD
Biomaterials; 2016 Mar; 81():157-168. PubMed ID: 26731578
[TBL] [Abstract][Full Text] [Related]
7. Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.
Chiodelli P; Bugatti A; Urbinati C; Rusnati M
Molecules; 2015 Apr; 20(4):6342-88. PubMed ID: 25867824
[TBL] [Abstract][Full Text] [Related]
8. Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo.
Mellor P; Harvey JR; Murphy KJ; Pye D; O'Boyle G; Lennard TW; Kirby JA; Ali S
Br J Cancer; 2007 Sep; 97(6):761-8. PubMed ID: 17726466
[TBL] [Abstract][Full Text] [Related]
9. The layered fold of the TSR domain of P. falciparum TRAP contains a heparin binding site.
Tossavainen H; Pihlajamaa T; Huttunen TK; Raulo E; Rauvala H; Permi P; Kilpeläinen I
Protein Sci; 2006 Jul; 15(7):1760-8. PubMed ID: 16815922
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts.
Delehedde M; Lyon M; Gallagher JT; Rudland PS; Fernig DG
Biochem J; 2002 Aug; 366(Pt 1):235-44. PubMed ID: 12000311
[TBL] [Abstract][Full Text] [Related]
11. Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.
Safran M; Eisenstein M; Aviezer D; Yayon A
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):107-13. PubMed ID: 10600645
[TBL] [Abstract][Full Text] [Related]
12. Decorin endocytosis: structural features of heparin and heparan sulphate oligosaccharides interfering with receptor binding and endocytosis.
Hausser H; Kresse H
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):827-35. PubMed ID: 10585870
[TBL] [Abstract][Full Text] [Related]
13. Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures.
Rusnati M; Tanghetti E; Urbinati C; Tulipano G; Marchesini S; Ziche M; Presta M
Mol Biol Cell; 1999 Feb; 10(2):313-27. PubMed ID: 9950679
[TBL] [Abstract][Full Text] [Related]
14. FGF-18, a novel member of the fibroblast growth factor family, stimulates hepatic and intestinal proliferation.
Hu MC; Qiu WR; Wang YP; Hill D; Ring BD; Scully S; Bolon B; DeRose M; Luethy R; Simonet WS; Arakawa T; Danilenko DM
Mol Cell Biol; 1998 Oct; 18(10):6063-74. PubMed ID: 9742123
[TBL] [Abstract][Full Text] [Related]
15. Lack of acidic fibroblast growth factor activation by heparan sulfate species from diabetic rat skin.
Bourin MC
Glycoconj J; 1997 Jun; 14(4):423-32. PubMed ID: 9249139
[TBL] [Abstract][Full Text] [Related]
16. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells.
Jayson GC; Gallagher JT
Br J Cancer; 1997; 75(1):9-16. PubMed ID: 9000592
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of fibroblast growth factors.
Wellstein A; Czubayko F
Breast Cancer Res Treat; 1996; 38(1):109-19. PubMed ID: 8825128
[TBL] [Abstract][Full Text] [Related]
18. Interaction of heparin with synthetic peptides corresponding to the C-terminal domain of intestinal mucins.
Xu G; Forstner GG; Forstner JF
Glycoconj J; 1996 Feb; 13(1):81-90. PubMed ID: 8785492
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican.
Steinfeld R; Van Den Berghe H; David G
J Cell Biol; 1996 Apr; 133(2):405-16. PubMed ID: 8609172
[TBL] [Abstract][Full Text] [Related]
20. Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation.
Venkataraman G; Sasisekharan V; Herr AB; Ornitz DM; Waksman G; Cooney CL; Langer R; Sasisekharan R
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):845-50. PubMed ID: 8570646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
